Jyothy Laboratories Intrinsic Value
JYOTHYLAB • Consumer Goods
Current Stock Price
₹213.36
Primary Intrinsic Value
₹208.00
Market Cap
₹789.4 Cr
+100.0%
Upside
Median Value
₹426.72
Value Range
₹64 - ₹533
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
JYOTHYLAB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹208.00 | ₹166.40 - ₹249.60 | -2.5% | EPS: ₹8.32, Sector P/E: 25x |
| Book Value Method | asset | ₹533.40 | ₹480.06 - ₹586.74 | +150.0% | Book Value/Share: ₹554.05, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹426.72 | ₹384.05 - ₹469.39 | +100.0% | Revenue/Share: ₹737.30, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹426.72 | ₹384.05 - ₹469.39 | +100.0% | EBITDA: ₹492.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹533.40 | ₹426.72 - ₹640.08 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹64.01 | ₹57.61 - ₹70.41 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹154.25 | ₹138.83 - ₹169.68 | -27.7% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹426.72 | ₹384.05 - ₹469.39 | +100.0% | ROE: 14.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹322.05 | ₹289.85 - ₹354.26 | +50.9% | EPS: ₹8.32, BVPS: ₹554.05 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
JYOTHYLAB Intrinsic Value Analysis
What is the intrinsic value of JYOTHYLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jyothy Laboratories (JYOTHYLAB) is ₹426.72 (median value). With the current market price of ₹213.36, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹64.01 to ₹533.40, indicating ₹64.01 - ₹533.40.
Is JYOTHYLAB undervalued or overvalued?
Based on our multi-method analysis, Jyothy Laboratories (JYOTHYLAB) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 10.77 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.01x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Jyothy Laboratories
Additional stock information and data for JYOTHYLAB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹311 Cr | ₹231 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹458 Cr | ₹286 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹329 Cr | ₹305 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹203 Cr | ₹187 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹402 Cr | ₹338 Cr | Positive Free Cash Flow | 8/10 |